Methods and compounds for controlled release of recombinant parvovirus vectors
CA 2410901 C · Owner: Rabinowitz, Joseph E. · Inventors: Samulski, Richard J.; Monahan, Paul E.; Rabinowitz, Joseph E.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention uses recombinant parvoviruses and particularly recombinant , adeno-associated virus (rAAV) to deliver genes and DNA sequences for gene therapy following manipulation of the therapeutic virus for packaging and transport. The invention delivers therapeutic viral vectors via rAAV affixed to support matrixes (i.e. sutures, surgically implantable materials grafts, and the like).
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 1, 2001 and granted March 20, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 1, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 1, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.